Access to medicines after TRIPS : is compulsory licensing an effective mechanism to lower drug prices? ; a review of the existing evidence
Eduardo Urias, Shyama V. Ramani
| Year of publication: |
2020
|
|---|---|
| Authors: | Urias, Eduardo ; Ramani, Shyama V. |
| Published in: |
Journal of International Business Policy : JIBP. - Basingstoke : Palgrave Macmillian, ISSN 2522-0705, ZDB-ID 2924287-3. - Vol. 3.2020, 4, p. 367-384
|
| Subject: | compulsory licensing | access to medicines | intellectual property protection | systematic review | pharmaceutical industry | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Immaterialgüterrechte | Intellectual property rights | TRIPS | Lizenz | Licence | Welt | World | Patentrecht | Patent law | Patent | Pharmakologie | Pharmacology | Gesundheitsversorgung | Health care |
Online Resource
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1057/s42214-020-00068-4 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10012405471